Difference between revisions of "Part:BBa K861072:Experience"

Line 7: Line 7:
 
===User Reviews===
 
===User Reviews===
 
<!-- DON'T DELETE --><partinfo>BBa_K861072 StartReviews</partinfo>
 
<!-- DON'T DELETE --><partinfo>BBa_K861072 StartReviews</partinfo>
<!-- Template for a user review
+
 
 
{|width='80%' style='border:1px solid gray'
 
{|width='80%' style='border:1px solid gray'
 
|-
 
|-
 
|width='10%'|
 
|width='10%'|
<partinfo>BBa_K861072 StartReviews</partinfo>
+
<partinfo>BBa_K861002 AddReview 1</partinfo>
<!-- End of the user review template -->
+
{|width='80%' style='border:1px solid gray'
+
|-
+
|width='10%'|
+
<partinfo>BBa_K861002 AddReview number</partinfo>
+
  
 
<I>iGEM2012 WHU-China</I>
 
<I>iGEM2012 WHU-China</I>

Revision as of 20:32, 26 September 2012

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K861072

User Reviews

UNIQ61362c662af5a17f-partinfo-00000000-QINU

iGEM2012 WHU-China

AdrA.jpg

As can be seen from the plate. Clone with AdrA constitutively expressed using BBa_J23107 is much more smaller compared to the control that only contain the plasmids of RBS. This result showed that the AdrA was successfully expressed leading to the increase expression of adhesins and inhibition of motility.

;

UNIQ61362c662af5a17f-partinfo-00000002-QINU